Results 271 to 280 of about 73,909 (338)

Proof of principle concept for the analysis and functional prediction of rare genetic variants in the CYP2C19 and CYP2D6 genes. [PDF]

Hum Genomics
Johansson I, Lu Y, Zhou Y, Krebs K, Akcan M, Milani L, Ingelman-Sundberg M.   +6 more
europepmc   +1 more source

Leveraging Omeprazole PBPK/PD Modeling to Inform Drug-Drug Interactions and Specific Recommendations for Pediatric Labeling. [PDF]

Pharmaceutics
Soliman A, Rodriguez-Vera L, Alarcia-Lacalle A, Pippa LF, Subhani S, Lukacova V, Duconge J, de Moraes NV, Vozmediano V.   +8 more
europepmc   +1 more source

Association between proton pump inhibitor use and the risk of myocardial infarction: A cross-sectional study based on NHANES 2007 to 2018. [PDF]

Medicine (Baltimore)
Zhang W, Yuan Z, Zhou J.
europepmc   +1 more source

Exploring the mechanisms and targets of proton pump inhibitors-induced osteoporosis through network toxicology, molecular docking, and molecular dynamics simulations. [PDF]

Front Pharmacol
Mu Y, Zhou Y, Zhang X, Shao Y.
europepmc   +1 more source

Drug-drug interactions: A descriptive analysis of FDA adverse event reporting system. [PDF]

Medicine (Baltimore)
Alahmari A, Fatani S, Ahmed N.
europepmc   +1 more source

<i>In vivo</i> effects of bempedoic acid on microdosed CYP probe drugs. [PDF]

Front Pharmacol
Stoll F, Amato S, Burhenne J, Blank A.
europepmc   +1 more source

Concomitant Gastrointestinal Bleeding Prophylaxis With Dual Antiplatelet Therapy Usage. [PDF]

Gastroenterology Res
Zhou DL, Tahir MM, Saleemi R, Kaur K, Shergill GPS.   +4 more
europepmc   +1 more source

A Systematic Review of the Adverse Effects of Long-Term Proton Pump Inhibitor Use on the Gastrointestinal System in the Adult Population. [PDF]

Cureus
Sekar Lakshmisai S, Bheemaneni RS, Nwachukwu EC, Nigam A, Sakarkar P, Khan S.   +5 more
europepmc   +1 more source